(Q71019976)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8609262%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

title

Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8609262%20AND%20SRC:MED&resulttype=core&format=json

lymphoproliferative disorders

15 October 2019

main subject

1 reference

inferred from title

lymphomatoid papulosis

1 reference

1 reference

E C Vonderheid

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8609262%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

A Sajjadian

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8609262%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

M E Kadin

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8609262%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

language of work or name

English

0 references

publication date

1 March 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8609262%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American Academy of Dermatology

15 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8609262%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8609262%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8609262%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

page(s)

470-481

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8609262%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

cites work

Lymphomatoid papulosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990442-9

7 January 2021

The clinical and histological spectrum of lymphomatoid papulosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990442-9

7 January 2021

Lymphomatoid papulosis. Characterization of skin infiltrates by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990442-9

7 January 2021

Atypical cells in lymphomatoid papulosis express the Hodgkin cell-associated antigen Ki-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990442-9

7 January 2021

Lymphomatoid papulosis expresses immunophenotypes associated with T cell lymphoma but not inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990442-9

7 January 2021

Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis. A European Multicenter Study of 47 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990442-9

7 January 2021

Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990442-9

7 January 2021

The prognosis of patients with lymphomatoid papulosis associated with malignant lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990442-9

7 January 2021

Lymphomatoid papulosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990442-9

7 January 2021

Methotrexate in lymphomatoid papulosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990442-9

7 January 2021

Treatment of lymphomatoid papulosis with methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990442-9

7 January 2021

Lymphomatoid papulosis. A follow-up study of 30 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990442-9

7 January 2021

Lymphomatoid papulosis: response to treatment with recombinant interferon alfa-2b

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990442-9

7 January 2021

Methotrexate in psoriasis: revised guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990442-9

7 January 2021

Karnofsky memorial lecture. Ode to methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990442-9

7 January 2021

10.1016/S0190-9622(96)90442-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8609262%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference